Showing 15 posts of 91 posts found.

Exscientia buys Austrian cancer cell screening company for €50 million

June 17, 2021
AI, EU, deal, marketing, sales

UK-based AI pioneers Exscientia has announced the purchase of rival AI firm Allcyte for €50 million. The multimillion deal, paid …

Deloitte acquires Iperion Life Sciences Consultancy

May 7, 2021
Medical Communications marketing, sales

Deloitte have announced the acquisition of Iperion Life Sciences Consultancy, a globally-operating firm working to support life sciences companies and …


Novartis CEO sets aside $700 million to settle bribery lawsuit

July 18, 2019
Business Services, Sales and Marketing Novartis, bribery, lawsuit, pharma, sales

Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States. Speaking in …


EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms

June 19, 2019
Research and Development EU, counterfeit, generics, pharma, sales

A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …


GSK to reintroduce bonuses for sales reps

May 24, 2019
Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal

British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …


Gilead to lay off one fifth of sales force

April 11, 2019
Sales and Marketing Gilead, Jobs, Letairis, Ranexa, redundancy, sales

Gilead Sciences is preparing to lay off around a fifth of its salesforce in anticipation for the expiry of patents …

Indian government set to colour code generic medicines

March 4, 2019
Sales and Marketing India, Indian health, costs, generic medicines, pricing, sales

As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …

Stripper-turned-Insys sales rep gave lap dance to persuade doctor to prescribe fentanyl

January 31, 2019
Medical Communications Sunrise Lee, US, chicago, corruption, insys, sales

A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …


Pfizer announces new UK Managing Director

December 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Osborne, EU, Leeds, Pfizer, sales

New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the …


Shire completes Baxalta takeover

June 3, 2016
Medical Communications, Research and Development, Sales and Marketing Baxalta, Shire, deal, merger and acquisition, revenue, sales

UK drugmaker Shire (LSE: SHP) on Friday announced the completion of merger with rare disease specialist Baxalta (NYSE: BXLT).  The …


AstraZeneca licenses gout drug Zurampic to Grünenthal in Europe and Latin America

June 2, 2016
Business Services, Manufacturing and Production, Sales and Marketing AstraZeneca, Grunenthal, Licencing, Zurampic, gout, sales

UK drugmaker AstraZeneca (LSE: AZN) on Thursday said it has entered into a licensing agreement worth up to $230 million …


Genmab receives milestone payment for first Darzalex sale in Europe

May 31, 2016
Manufacturing and Production, Sales and Marketing EU, FDA, Janssen, commercial, commercialised, daratumumab, darzalex, genman, multiple myeloma, sale, sales

Genmab (NASDAQ: GEN) has announced that the company is set to receive a milestone payment of $30 million from its …


Merck & Co Q1 sales hurt by generics, currency impact

May 6, 2016
Medical Communications, Sales and Marketing Financial, Merck & Co, Q1, Revenye, earnings, results, sales

US pharma major Merck & Co (NYSE: MRK) posted a drop in first-quarter sales impacted the launch of generic competition …

Pfizer revenue jumps 20%; ups FY16 outlook

May 4, 2016
Research and Development, Sales and Marketing Pfizer, Q1, earnings, results, revenue, sales

US pharma giant Pfizer (NYSE: PFE) reported a 20% jump in first-quarter revenue boosted by performance of its new cancer …

Latest content